BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NNC0537-1482 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of NNC0537-1482\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07218627-633@assetmemo.bio
DTSTAMP:20261121T010138Z
DTSTART;VALUE=DATE:20270115
DTEND;VALUE=DATE:20270116
SUMMARY:NNC0537-1482: Phase 1 readout est. (NCT07218627)
DESCRIPTION:NNC0537-1482\, phase 1\, Heart Failure.\nStudy: A Research Stud
 y on the Effects of NNC0537-1482 in Participants With Heart Failure\nEstim
 ated primary completion: 15 January 2027. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/nnc0537-1482#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT07218627
URL:https://assetmemo.bio/drug/nnc0537-1482#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07808788-633@assetmemo.bio
DTSTAMP:20261121T010138Z
DTSTART;VALUE=DATE:20270706
DTEND;VALUE=DATE:20270707
SUMMARY:NNC0537-1482: Phase 1 readout est. (NCT07808788)
DESCRIPTION:NNC0537-1482\, phase 1.\nStudy: A Research Study Looking Into H
 ow a Single Dose of the Medicine NNC0537-1482 Moves Through the Body of Pa
 rticipants With Normal or Reduced Kidney Function\nEstimated primary compl
 etion: 6 July 2027. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/n
 nc0537-1482#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT07808788
URL:https://assetmemo.bio/drug/nnc0537-1482#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
